Loading...
 

Volume 28, Issue 3, September 2017

Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2017; 28(3):18-28
The clinical utility of gene expression examination in rheumatology
Authors Information

Immunology and Molecular Biology Laboratory, Nasonova Research Institute of Rheumatology, Moscow, Russia

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease with unknown etiology that affects various pathways within the immune system, involves many other tissues and is associated with pain and joint destruction. Current treatments fail to address pathophysiological and biochemical mechanisms involved in joint degeneration and the induction of pain. Moreover, RA patients are extremely heterogeneous and require specific treatments, the choice of which is complicated by the fact that not all patients equally respond to therapy. Gene expression analysis offer tools for patient management and personalization of patient’s care to meet individual needs in controlling inflammation and pain and delaying joint destruction.